Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 7, 2022; 28(21): 2251-2281
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2251
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2251
Table 1 Hepatocellular carcinoma incidence and risk factors
| Location | Chronic HBV infection | Chronic HCV infection | Alcoholic liver disease | Non-alcoholic steatohepatitis | ||||
| NC | CC | NC | CC | NC | CC | NC | CC | |
| Europe | 0.12 | 2.2 | 0-1.8 | 3.7 | 0.1 | 1.8 | 0.5 | 1.1 |
| East Asia | 0.8 | 4.3 | F0/1 0.4; F2 1.5; F3 5.1 | 7.1 | 0.1 | 1.7 | a | a |
- Citation: Stella L, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World J Gastroenterol 2022; 28(21): 2251-2281
- URL: https://www.wjgnet.com/1007-9327/full/v28/i21/2251.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i21.2251